Pilot trial of an online Acceptance and Commitment Therapy course to help People with Multiple Sclerosis who want to stay in work

Preventing job loss using Acceptance and Commitment Therapy in Vocational Rehabilitation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14056874

Enrollment

Registered

2020-12-22

Start date

2020-08-13

Completion date

Unknown

Last updated

2021-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis Nervous System Diseases Multiple Sclerosis

Interventions

The adaptation of READY for MS and set up will last 6 months. The research team will work with a digital design company to develop the online version of READY for MS. Four PwMS will test the new onlin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of multiple sclerosis 2. Paid employment including full-time or part-time work and self-employed 3. Aged =18 years 4. Access to a computer or tablet for the on-line sessions 5. Ability to complete questionnaires at three timepoints

Exclusion criteria

Exclusion criteria: 1. Unpaid employment such as voluntary work 2. Planning to retire or fully leave employment in the time period of the study 3. On sick leave or maternity leave at the time of recruitment 4. Significant cognitive impairment

Design outcomes

Primary

Measure	Time frame
1. Work instability measured using the MS Work Instability Scale (MS WIS) at screening, baseline, and 6 months	—

Secondary

Measure	Time frame
1. Health-related quality of life measured using the Euroqol 5 -dimension (EQ-5D) index and the 12-Item Short Form Survey (SF-12) at baseline and 6 months 2. Mood measured using the Hospital Anxiety and Depression Scale (HADS) at baseline and 6 months 3. Self-efficacy measured using the Uni-dimensional Self-efficacy Scale for Multiple Sclerosis (USE-MS) at baseline and 6 months 4. Impact of MS measured using the Multiple Sclerosis Impact Scale-29, (MSIS-29) at baseline and 6 months 5. Fatigue measured using the Neurological Fatigue Index for Multiple Sclerosis (NFI-MS) at baseline and 6 months 6. Psychological flexibility measured using the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompPACT) at baseline and 6 months 7. Participant satisfaction with the technology post-intervention measured using the System Usability Scale (SUS) at baseline and 6 months	—

Measure

Time frame

1. Health-related quality of life measured using the Euroqol 5 -dimension (EQ-5D) index and the 12-Item Short Form Survey (SF-12) at baseline and 6 months 2. Mood measured using the Hospital Anxiety and Depression Scale (HADS) at baseline and 6 months 3. Self-efficacy measured using the Uni-dimensional Self-efficacy Scale for Multiple Sclerosis (USE-MS) at baseline and 6 months 4. Impact of MS measured using the Multiple Sclerosis Impact Scale-29, (MSIS-29) at baseline and 6 months 5. Fatigue measured using the Neurological Fatigue Index for Multiple Sclerosis (NFI-MS) at baseline and 6 months 6. Psychological flexibility measured using the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompPACT) at baseline and 6 months 7. Participant satisfaction with the technology post-intervention measured using the System Usability Scale (SUS) at baseline and 6 months

—

Countries

England, United Kingdom

Contacts

Public ContactCharlotte Wicks

charlotte.wicks1@nhs.net+44 (0)113 3925073

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026